Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin inks pact with Exeltis to promote Solosec drug in US
As part of the tie-up, Exeltis will promote Solosec along with its existing line of women's health products
19th edition of BioAsia to kick-start on 24th February
The two-day edition will focus on the future readiness of the lifesciences industry
Why India’s budget needs to provide a boost to develop pharmaceutical sector
Sudesh Verma, Member, National Media Relations Department, BJP, explains the need to showcase grit and determination to take…
DCGI approves “Conditional Market Authorisation” of Covaxin and Covishield
The approval pathways through this route are fast-tracked with certain conditions to enhance the access to certain pharmaceuticals…
COVID-19 brought positives for pharma industry
Antony Prashant, Partner, Deloitte India, sheds light on the various aspects that led to the growth of the Indian pharma industry…
Mix-and-match trial finds additional dose of COVID-19 vaccine safe and immunogenic
All combinations of primary and booster vaccine resulted in increased neutralising antibody levels (ranging from 4.2- to 76-fold…
Israel broadens eligibility for fourth shot of COVID vaccine
Earlier this month, Israel began offering the fourth jab to people over 60, on the condition that at least five months have passed…
Lonza’s full-year core EBITDA up 20.7 per cent on vaccine demand
Full-year core earnings before interest, tax, depreciation and amortisation (EBITDA) rose to 1.67 billion Swiss francs ($1.82…
Each dose of Covishield and Covaxin likely to be capped at Rs 275 after getting regular market…
National Pharmaceutical Pricing Authority (NPPA) has been directed to start working towards capping the price to make the vaccines…
Sun Pharma launches Cequa, maiden dry eye treatment with nanomicellar technology in Canada
Cequa’s nanomicellar (NCELL) technology improves the bioavailability and physicochemical stability of cyclosporine to increase…